(Total Views: 615)
Posted On: 06/13/2019 9:25:41 AM
Post# of 149743
$CYDY News Article - CytoDyn to Present Pivotal Data at ASM Microbe 2019 Demonstrating Efficacy and Safety of Leronlimab (PRO 140) in HIV Patients with Multiple ARV Class Resistance https://marketwirenews.com/news-releases/cyto...49344.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
